Biofrontera (BFRI)

• Market cap: $10.4M
• 1 day: -24.39%
• 5 days: -16.65%
• 1 month: -21.53%
• 3 months: -44.44%
• 6 months: -27.06%
• Year to date: -3.43%
• 1 year: -21.35%
• 5 years: -98.88%
• 10 years: -99.21%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Employees: 94